samedan logo

home > news > detailed info

Envirotainer praises industry collaboration as it handles billionth vaccine


Omicron surge prompts the need for even greater planning to deliver the next billion doses

Stockholm, December 22, 2021:
Envirotainer, the global market leader in secure cold-chain solutions for air transportation of pharmaceuticals, is calling for continued collaboration between pharmaceutical firms and the logistics industry.

The call to action comes as Envirotainer passes a major milestone in the shipment of COVID-19 vaccines. One billion have been carried in the company’s fleet of over 6,500 temperature-controlled air cargo containers. These are designed to maintain constant internal temperature, some for over a week, ensuring treatments arrive in perfect condition.

With much of Europe introducing new curbs on freedoms to reduce cases[i], the whole sector needs to be ready to meet increased demand for vaccines and boosters.

Globally, just 56.9 per cent of the world population has received one dose of a COVID-19 vaccine[ii]. This illustrates the mountain left to climb. In doing so, pharmaceutical manufacturers, forwards, airlines and cold chain-solutions providers need to work seamlessly as extensions of each other.

This calls for total transparency on which consignments are crucial and need to be prioritised. It also requires further advance planning. Not only in terms of keeping COVID-19 treatments moving, but also other life-saving drugs that are required every day across the globe.

Niklas Adamsson, Envirotainer’s Chief Operating Officer said: “We’re incredibly proud of handling a billion vaccines at a time when air freight has been restricted and demand has been sky high. This is thanks to the incredible collaboration we’ve been part of across the industry.

“We’ve worked closely with our partners and customers, and now want to work even closer with those efforts in the face of Omicron. It’s crucial we continue to work in unity across the cold-chain to get the next doses to the patients, where they’re needed. It’s our responsibility as part of the fight against coronavirus, and we’re ready to do all we can.”
phone +46 18 34 73 00
email Head office R&D Manufacturing, Envirotainer AB, Lagga Marma, SE-741 93 Knivsta, Sweden
Print this page
Send to a friend
News and Press Releases

AffyXell Expands its Strategic Partnership with GenScript ProBio

London and Wetherby, UK, 16 May 2022: Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, is pleased to announce that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded its strategic partnership with GenScript ProBio, a leading biopharmaceutical manufacturer.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

Industry Events

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)

20-21 June 2022, Berlin, Germany

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to discuss the manufacturing and packaging processes of the pharmaceutical industry. Among the participating companies are Bayer, Sandoz, Merck, Novartis, Roche, Genveon, Samsung Biologics, Pfizer.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement